Medical Oncologist
While you are on Pazopanib
Tests and Monitoring — While You Are on Pazopanib
Pazopanib requires more monitoring than most oral treatments. Knowing which tests are done, how often, and what each result means helps you keep to the schedule — and act quickly when something needs attention.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Liver tests come first — Liver function is checked most frequently in the first few months, when changes are most likely to appear.
- Blood pressure matters every week early on — Hypertension is common on pazopanib and is monitored regularly, especially in the first several weeks.
- Feeling well does not mean tests can wait — Liver and thyroid changes can happen without any symptoms. The tests are looking for things you will not feel.
- Abnormal results are manageable — Most monitoring findings lead to a dose adjustment or a short pause — not to stopping treatment permanently.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
While you are on pazopanib, you will have regular liver function tests, blood pressure monitoring, thyroid checks, urine protein tests, and blood counts. NCCN guidance schedules liver tests at weeks three, five, seven and nine initially, and blood pressure weekly for the first several weeks. Each test is watching a specific organ the drug can affect.
Why does pazopanib need this much monitoring?
Pazopanib blocks signals that tumours use to grow their own blood supply. Those same pathways run through your liver, blood vessels, thyroid, and kidneys — which is why those organs are watched closely while you are on treatment.
The first two to three months carry the most intensive schedule. That is when changes in liver enzymes and blood pressure are most likely to appear for the first time.
These tests are safety checks, not response assessments. Your scans tell you whether the treatment is working. Your blood tests tell your team whether it is safe to continue at the current dose.
Which tests are done, how often, and what each one watches
Liver function tests — ALT, AST, bilirubin
This is the most closely watched test on pazopanib. NCCN guidance recommends checking at baseline and then at weeks three, five, seven and nine. After that, monitoring continues monthly for about four months, then periodically. Raised liver enzymes are the most common reason for a dose pause or reduction. Most cases are caught and managed without lasting harm because of this early, frequent schedule.
Blood pressure
Hypertension is one of the most common effects of pazopanib. Your team will check it at baseline and ask you to monitor it at home, particularly in the first several weeks. NCCN guidance supports weekly monitoring early in treatment. If your blood pressure rises, it is usually managed with medication — treated high blood pressure does not mean pazopanib has to stop.
Thyroid function — TSH
Pazopanib can reduce thyroid hormone levels over time. This is checked at baseline and periodically during treatment. Hypothyroidism on pazopanib often produces no symptoms until it is moderate, which is why the blood test matters more than how you feel. If your TSH rises, thyroid replacement tablets correct it quickly and treatment continues.
Urine protein
Protein in the urine can be an early sign that pazopanib is affecting the kidney's filtering system. A urine dipstick is done at baseline and at intervals during treatment. A trace of protein is common and usually watched rather than acted on immediately. Higher levels prompt a more detailed urine collection to measure the amount accurately.
Full blood count and kidney function
Pazopanib is not primarily a bone marrow suppressant, but blood counts and creatinine are checked at baseline and periodically as part of overall safety monitoring. These tests also help your team interpret other results in context — dehydration, for example, can change how creatinine and other values look.
ECG — heart trace
Pazopanib can affect the electrical activity of the heart, measured as the QT interval on an ECG. A baseline ECG is typically done before you start, and your team checks whether any other medicines you take could add to this effect. Routine repeat ECGs are not always required but may be ordered if your team identifies a specific concern.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What happens when a result is outside the normal range?
An abnormal result does not automatically mean pazopanib stops. Most findings lead to a short pause, a dose reduction, or the addition of a medicine to manage the problem — then a recheck to confirm things are improving.
Liver enzyme rises are graded from mild to severe. Mild rises are usually watched with more frequent testing and continued treatment. Moderate rises typically prompt a pause while levels return toward normal, then a restart, sometimes at a lower dose. Severe rises are uncommon when the early schedule is kept.
The key point is that acting on an early result is nearly always simpler than managing a problem that was not caught. This is why the week-three, five, seven and nine schedule exists — not as a formality, but as the window when most significant changes appear.
How to make your monitoring schedule work
- Book your week-three blood test before you leave with your first prescription — that appointment is easy to lose track of.
- Get a home blood pressure monitor if you do not already have one, and bring a written log of your readings to every appointment.
- Tell your team every medicine, supplement, and herbal preparation you take. Some interact with pazopanib or affect the way test results are interpreted.
- Do not skip a test because you feel well — liver enzyme changes and thyroid changes rarely cause noticeable symptoms until they are significant.
- Know the number to call if you feel unwell between appointments. Yellow skin or eyes, dark urine, or sudden severe fatigue need a same-day call.
- Tell your dentist and any other treating doctor that you are on pazopanib, especially before any procedure.
Did you know?
Liver toxicity is the most common reason pazopanib is paused or stopped — and also one of the most preventable consequences of missing an early blood test.
The weeks-three, five, seven and nine schedule recommended by NCCN exists specifically because most significant liver enzyme rises appear in this window, not randomly across the treatment course.
Source: NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer
Explore 75 more Kidney, Ovarian & Sarcoma Targeted Medicines topics
Drug Deep Dive: Pazopanib (Votrient)
- Diarrhoea and Blood Pressure Rise on Pazopanib
- Diet and Nutrition While on Pazopanib
- Drug, Food and Supplement Interactions With Pazopanib
- Fertility, Pregnancy and Contraception on Pazopanib
- Hair Turning White and Skin Lightening on Pazopanib
- How Does Pazopanib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Pazopanib Take to Work?
- How Long Will You Stay on Pazopanib?
- Liver Toxicity on Pazopanib: Why LFTs Are Checked Every Two Weeks
- Pazopanib (Votrient, Pazonib): The Complete Patient Guide
- Pazopanib Combinations: Why It Is Usually Given Alone
- Pazopanib Myths: Hair Colour, Liver Damage and Stopping Early
- Pazopanib Price in India: Brand, Generic and Monthly Cost
- Pazopanib Side Effects: The Complete List and Timeline
- Pazopanib Success Rate and Survival: An Honest Look at the Numbers
- Pazopanib for Soft Tissue Sarcoma: What It Can and Cannot Do
- Pazopanib in Elderly Patients and Those With Other Illnesses
- Pazopanib in Kidney Cancer vs Sarcoma: Two Different Treatment Goals
- Pazopanib vs Sunitinib: Comparing Toxicity and Quality of Life
- Taking Pazopanib on an Empty Stomach: Why the Timing Rule Exists
- Tests and Monitoring While You Are on Pazopanib
- When Pazopanib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Pazopanib? Kidney Cancer and Soft Tissue Sarcoma
- Will Insurance or a Government Scheme Pay for Pazopanib?
- Work, Travel and Daily Life on Pazopanib
Drug Deep Dive: Olaparib (Lynparza)
- Adjuvant Olaparib After Early Breast Cancer Surgery
- Anaemia and Extreme Fatigue on Olaparib
- Blood Cancer Risk After Long-Term Olaparib: How Real Is It?
- Diet and Nutrition While on Olaparib
- Drug, Food and Supplement Interactions With Olaparib
- Fertility, Pregnancy and Contraception on Olaparib
- How Does Olaparib Work? The PARP Inhibitor Explained
- How Long Does Olaparib Take to Work?
- How Long Will You Stay on Olaparib?
- Maintenance Olaparib: Taking a Drug When There Is No Visible Cancer
- Nausea on Olaparib: Managing the Most Common Side Effect
- Olaparib (Lynparza, Olanib): The Complete Patient Guide
- Olaparib Myths: 'Only for BRCA', 'It's Chemo', 'It Causes Cancer'
- Olaparib Price in India: Brand, Generic and Monthly Cost
- Olaparib Side Effects: The Complete List and Timeline
- Olaparib Success Rate and Survival: An Honest Look at the Numbers
- Olaparib With Bevacizumab or Hormone Therapy: Combination Regimens
- Olaparib in Elderly Patients and Those With Other Illnesses
- Olaparib vs Niraparib vs Talazoparib: Comparing PARP Inhibitors
- Taking Olaparib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Olaparib
- When Olaparib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Olaparib? BRCA-Mutated Ovarian, Breast, Prostate and Pancreatic Cancer
- Will Insurance or a Government Scheme Pay for Olaparib?
- Work, Travel and Daily Life on Olaparib
Drug Deep Dive: Sunitinib (Sutent)
- Diet and Nutrition While on Sunitinib
- Drug, Food and Supplement Interactions With Sunitinib
- Fertility, Pregnancy and Contraception on Sunitinib
- Hand-Foot Skin Reaction on Sunitinib: Prevention From Day One
- How Does Sunitinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sunitinib Take to Work?
- How Long Will You Stay on Sunitinib?
- Mouth Sores, Taste Loss and Yellow Skin Discolouration on Sunitinib
- Sunitinib (Sutent, Sunitix): The Complete Patient Guide
- Sunitinib After Kidney Surgery and for GIST: Two Different Settings
- Sunitinib Myths: Hair Colour Change, Dose Cuts and 'Weaker Treatment'
- Sunitinib Price in India: Brand, Generic and Monthly Cost
- Sunitinib Side Effects: The Complete List and Timeline
- Sunitinib Success Rate and Survival: An Honest Look at the Numbers
- Sunitinib and Immunotherapy: Where Combinations Fit in Kidney Cancer
- Sunitinib in Elderly Patients and Those With Other Illnesses
- Sunitinib vs Pazopanib vs Cabozantinib for Kidney Cancer
- Taking Sunitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sunitinib
- The 4-Weeks-On, 2-Weeks-Off Sunitinib Schedule and the 2/1 Alternative
- Thyroid Failure and Fatigue on Sunitinib: The Test to Repeat Every Cycle
- When Sunitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sunitinib? Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumours
- Will Insurance or a Government Scheme Pay for Sunitinib?
- Work, Travel and Daily Life on Sunitinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Can I skip blood tests if I feel well on pazopanib?
No, and this is one of the most important things to understand about this medicine. Liver enzyme changes and hypothyroidism are the two most common monitoring findings on pazopanib, and neither reliably causes symptoms until the levels are at a point that is harder to manage. The blood tests are looking for things you will not feel. Missing a test — especially in the first two to three months — removes the early warning that makes the response straightforward.
What does it mean if my liver results are raised?
It means your team will look at how much they have risen and compare them with your previous results. A mild rise is usually managed with more frequent testing and continued treatment. A moderate rise typically means a short pause while levels return toward normal, then a restart, sometimes at a lower dose. Severe rises are uncommon when monitoring is kept to schedule, but if one occurs the drug is stopped. Most people whose enzyme rises are caught early continue treatment successfully.
How should I monitor my blood pressure at home?
Sit quietly for five minutes before measuring. Take the reading on the same arm each time, ideally in the morning before your pazopanib dose. Note the date, time, and both numbers. Bring the written log to your appointments. Ask your team what reading should prompt you to call the same day rather than waiting — they will give you a specific target for your situation, because the right threshold varies from person to person.
Will the monitoring schedule mean very frequent clinic visits?
Blood tests in the early months can often be done at a local collection centre rather than at your cancer centre, so they do not always mean a full clinic visit. Ask your team whether a nearby laboratory is possible for your routine draws. Review appointments — where results are discussed — are scheduled around the test dates. After the intensive early period, monitoring becomes considerably less frequent as the risk profile lowers once you are established on treatment.
What happens if my results mean I have to pause pazopanib?
A pause is a clinical decision, not a sign that treatment has failed. Your team will stop the drug temporarily, recheck the relevant results after an interval, and restart when levels have improved. Many people restart successfully, sometimes at a slightly lower dose. The pause itself is generally short. What matters is that the decision is made early — catching a liver enzyme rise at week five is far simpler to manage than one that was missed for several months.